BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17785554)

  • 1. Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
    Signoroni S; Frattini M; Negri T; Pastore E; Tamborini E; Casieri P; Orsenigo M; Da Riva L; Radice P; Sala P; Gronchi A; Bertario L; Pierotti MA; Pilotti S
    Clin Cancer Res; 2007 Sep; 13(17):5034-40. PubMed ID: 17785554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
    Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
    Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
    Tamborini E; Miselli F; Negri T; Lagonigro MS; Staurengo S; Dagrada GP; Stacchiotti S; Pastore E; Gronchi A; Perrone F; Carbone A; Pierotti MA; Casali PG; Pilotti S
    Clin Cancer Res; 2006 Dec; 12(23):6920-8. PubMed ID: 17145809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
    Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
    Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
    Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
    Heinrich MC; McArthur GA; Demetri GD; Joensuu H; Bono P; Herrmann R; Hirte H; Cresta S; Koslin DB; Corless CL; Dirnhofer S; van Oosterom AT; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2006 Mar; 24(7):1195-203. PubMed ID: 16505440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
    Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
    Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
    Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
    Lips DJ; Barker N; Clevers H; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
    Tejpar S; Nollet F; Li C; Wunder JS; Michils G; dal Cin P; Van Cutsem E; Bapat B; van Roy F; Cassiman JJ; Alman BA
    Oncogene; 1999 Nov; 18(47):6615-20. PubMed ID: 10597266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
    Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A
    Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormalities of chromosome 8, APC and beta-catenin genes in aggressive fibromatosis].
    Yang JL; Wang J; Zhou XY; Zhu XZ
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):116-20. PubMed ID: 18646694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression.
    Matono H; Tamiya S; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M; Oda Y
    Histopathology; 2011 Sep; 59(3):368-75. PubMed ID: 22034877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
    Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
    Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm.
    Wang WL; Nero C; Pappo A; Lev D; Lazar AJ; López-Terrada D
    Pediatr Dev Pathol; 2012; 15(5):361-7. PubMed ID: 22372443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K; Singh S; Schirmacher P; Bläker H
    J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).
    Poon R; Smits R; Li C; Jagmohan-Changur S; Kong M; Cheon S; Yu C; Fodde R; Alman BA
    Oncogene; 2001 Jan; 20(4):451-60. PubMed ID: 11313976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
    Kohler EM; Chandra SH; Behrens J; Schneikert J
    Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of β-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis.
    Bo N; Wang D; Wu B; Chen L; Ruixue Ma
    Pediatr Dev Pathol; 2012; 15(3):173-8. PubMed ID: 21323417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.